CTOR Competitors & Alternatives

Compare Citius Oncology, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

CTOR

Main Stock
$0.95
Tradestie Score
37
Market Cap
$164.52M
Analyst Upside
+321.1%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.55
$711.32M - 67 Compare
ESPR Esperion Therapeutics, Inc.
$3.18
$584.71M - 53 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$55.36
$543.32M 133.3 61 Compare
EOLS Evolus, Inc. Common Stock
$7.14
$397.82M - 42 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.64
$237.15M 5.0 60 Compare
KAPA Kairos Pharma, Ltd.
$1.56
$23.44M - 44 Compare
SLXN Silexion Therapeutics Corp Ordinary Shares
$0.26
$11.85M - 49 Compare
IBO Impact BioMedical, Inc.
$5.32
$7.84M 0.5 31 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$9.61
$6.53M - 45 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$0.13
$4.04M 0.0 50 Compare

Data updated: Oct 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry